DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 892 filers reported holding DANAHER CORPORATION in Q1 2014. The put-call ratio across all filers is 0.37 and the average weighting 0.5%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $431,000 | +29.8% | 1,940 | +26.0% | 0.09% | +60.3% |
| Q3 2020 | $332,000 | +7.8% | 1,540 | -11.5% | 0.06% | -13.4% |
| Q2 2020 | $308,000 | +14.5% | 1,740 | -10.3% | 0.07% | -6.9% |
| Q1 2020 | $269,000 | -8.8% | 1,940 | +1.0% | 0.07% | +16.1% |
| Q4 2019 | $295,000 | +1.0% | 1,920 | -5.0% | 0.06% | -10.1% |
| Q3 2019 | $292,000 | +1.0% | 2,020 | -0.2% | 0.07% | +1.5% |
| Q2 2019 | $289,000 | +19.9% | 2,025 | +11.0% | 0.07% | +13.3% |
| Q1 2019 | $241,000 | +16.4% | 1,825 | -9.2% | 0.06% | +3.4% |
| Q4 2018 | $207,000 | +4.5% | 2,010 | +10.1% | 0.06% | +26.1% |
| Q3 2018 | $198,000 | +10.0% | 1,825 | 0.0% | 0.05% | 0.0% |
| Q2 2018 | $180,000 | -7.2% | 1,825 | -8.0% | 0.05% | -8.0% |
| Q1 2018 | $194,000 | +5.4% | 1,984 | 0.0% | 0.05% | -12.3% |
| Q4 2017 | $184,000 | +8.2% | 1,984 | 0.0% | 0.06% | +1.8% |
| Q3 2017 | $170,000 | +1.8% | 1,984 | 0.0% | 0.06% | -1.8% |
| Q2 2017 | $167,000 | -1.8% | 1,984 | 0.0% | 0.06% | 0.0% |
| Q1 2017 | $170,000 | +6.2% | 1,984 | -3.3% | 0.06% | +1.8% |
| Q4 2016 | $160,000 | -24.9% | 2,051 | -24.3% | 0.06% | -26.3% |
| Q3 2016 | $213,000 | -22.3% | 2,711 | 0.0% | 0.08% | -26.2% |
| Q2 2016 | $274,000 | +20.2% | 2,711 | +12.7% | 0.10% | +19.8% |
| Q1 2016 | $228,000 | -11.3% | 2,406 | -13.1% | 0.09% | -13.1% |
| Q4 2015 | $257,000 | +8.9% | 2,769 | 0.0% | 0.10% | +10.0% |
| Q3 2015 | $236,000 | -8.5% | 2,769 | -8.3% | 0.09% | -3.2% |
| Q2 2015 | $258,000 | +0.8% | 3,019 | 0.0% | 0.09% | +1.1% |
| Q1 2015 | $256,000 | +12.8% | 3,019 | +13.9% | 0.09% | +9.5% |
| Q4 2014 | $227,000 | +7.6% | 2,650 | -4.7% | 0.08% | +5.0% |
| Q3 2014 | $211,000 | -11.7% | 2,780 | -8.6% | 0.08% | -16.7% |
| Q2 2014 | $239,000 | -6.6% | 3,040 | -11.1% | 0.10% | -15.0% |
| Q1 2014 | $256,000 | -3.0% | 3,420 | 0.0% | 0.11% | -3.4% |
| Q4 2013 | $264,000 | +11.4% | 3,420 | 0.0% | 0.12% | +3.5% |
| Q3 2013 | $237,000 | +9.7% | 3,420 | 0.0% | 0.11% | +1.8% |
| Q2 2013 | $216,000 | – | 3,420 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CROSBY Co OF NEW HAMPSHIRE LLC | 224,667 | $17,688,000 | 10.64% |
| RobecoSam USA, Inc. | 102,422 | $8,063,000 | 8.78% |
| CORTLAND ASSOCIATES INC/MO | 466,424 | $36,722,000 | 7.33% |
| Red Rocks Capital LLC | 324,527 | $25,550,000 | 7.05% |
| Five Oceans Asset Management LTD | 327,112 | $25,754,000 | 5.88% |
| Robeco Schweiz AG | 739,101 | $58,529,000 | 4.77% |
| TRAN CAPITAL MANAGEMENT, L.P. | 3,428,966 | $269,962,000 | 4.72% |
| ASHMORE WEALTH MANAGEMENT LLC | 3,000,000 | $236,192,000 | 4.56% |
| BI Asset Management Fondsmaeglerselskab A/S | 503,250 | $39,621,000 | 4.31% |
| CADINHA & CO LLC | 324,429 | $25,542,000 | 4.31% |